Drugs / Process Upgrade Varicella Vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00986232 Comparator | Apr 1999 → Apr 2000 | chickenpox, measles, mumps infectious disease, rubella | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Process Upgrade Varicella Vaccine | “Process Upgrade Varicella Vaccine (PUVV)” NCT00986232 ↗ |
| Known as | PUVV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00986232 ↗ |
| Modality | Vaccine | “A Study comparing three different doses of ProQuad to concomitant administration of M-M-R II and PUVV (Process Upgrade Varicella Vaccine) vaccines.” NCT00986232 ↗ |